We are live on ! Find out more
SCM

SKBA Capital Management Portfolio holdings

AUM $728M
1-Year Est. Return 12.18%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+12.18%
3 Year Est. Return
+52.29%
5 Year Est. Return
+76.86%
10 Year Est. Return
+235.51%
AUM
$594M
AUM Growth
+$51.9M
Cap. Flow
-$572K
Cap. Flow %
-0.1%
Top 10 Hldgs %
30.45%
Holding
82
New
6
Increased
17
Reduced
44
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.91M
2
KVUE icon
Kenvue
KVUE
+$7.91M
3
HAS icon
Hasbro
HAS
+$5.48M
4
LHX icon
L3Harris
LHX
+$5.22M
5
PNW icon
Pinnacle West Capital
PNW
+$3.22M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.34M
2
NTR icon
Nutrien
NTR
+$5.27M
3
AZN icon
AstraZeneca
AZN
+$4.98M
4
OGE icon
OGE Energy
OGE
+$4.79M
5
GLW icon
Corning
GLW
+$4.63M

Sector Composition

Rank Sector Weight
1 Financials 18.35%
2 Healthcare 13.46%
3 Consumer Discretionary 12.76%
4 Technology 11.08%
5 Industrials 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COHR icon
76
Coherent
COHR
$74.2B
$201K 0.03%
+4,610
New +$166K
AZN icon
77
AstraZeneca
AZN
$250B
– –
-36,768
Closed -$4.98M
BMY icon
78
Bristol-Myers Squibb
BMY
$132B
– –
-3,700
Closed -$215K
GLW icon
79
Corning
GLW
$143B
– –
-151,895
Closed -$4.63M
NTR icon
80
Nutrien
NTR
$30.7B
– –
-85,340
Closed -$5.27M
OGE icon
81
OGE Energy
OGE
$9.71B
– –
-143,760
Closed -$4.79M
SLB icon
82
SLB Ltd
SLB
$75B
– –
-3,490
Closed -$203K
1 2 3
4

Similar funds

SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return

SKBA Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, SKBA Capital Management held 82 positions worth $594M, up 9.6% from $542M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

SKBA Capital Management's Q4 2023 filing shows 6 new, 17 increased, 44 reduced and 6 closed positions. Its largest new stake was Pfizer: 294,600 shares worth $8.48M. The largest sale was Amgen, an estimated $5.34M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • SKBA Capital Management's largest Q4 2023 buy was Pfizer: 294,600 shares worth $8.48M.
  • SKBA Capital Management added most to Pinnacle West Capital in Q4 2023, an estimated $3.22M increase.
  • SKBA Capital Management's biggest Q4 2023 reduction was Amgen, cutting an estimated $5.34M.
  • SKBA Capital Management fully exited Nutrien in Q4 2023, selling an estimated $5.27M.
  • SKBA Capital Management's ten largest holdings make up 30% of its $594M portfolio in Q4 2023.
  • SKBA Capital Management opened 6 new positions and closed 6 in Q4 2023.
  • SKBA Capital Management's portfolio value rose 9.6% quarter-over-quarter to $594M.

Based on SKBA Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.